5AM Venture Management as of Sept. 30, 2025
Portfolio Holdings for 5AM Venture Management
5AM Venture Management holds 25 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Skye Bioscience Com New (SKYE) | 13.9 | $38M | 9.7M | 3.93 | |
| Entrada Therapeutics (TRDA) | 9.0 | $25M | 4.3M | 5.80 | |
| Pharvaris N V (PHVS) | 7.3 | $20M | 798k | 24.95 | |
| Camp4 Therapeutics Corp (CAMP) | 6.4 | $18M | 5.9M | 3.00 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 6.0 | $17M | 681k | 24.25 | |
| Miragen Therapeutics (VRDN) | 5.8 | $16M | 737k | 21.58 | |
| Enliven Therapeutics (ELVN) | 5.8 | $16M | 773k | 20.47 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 5.5 | $15M | 1.1M | 14.24 | |
| Dianthus Therapeutics (DNTH) | 5.3 | $14M | 365k | 39.35 | |
| Tyra Biosciences (TYRA) | 4.8 | $13M | 939k | 13.99 | |
| Celldex Therapeutics Com New (CLDX) | 4.7 | $13M | 497k | 25.87 | |
| Erasca (ERAS) | 4.3 | $12M | 5.4M | 2.18 | |
| Praxis Precision Medicines I Com New (PRAX) | 3.3 | $9.0M | 170k | 53.00 | |
| Gh Research Ordinary Shares (GHRS) | 3.0 | $8.2M | 573k | 14.30 | |
| Tectonic Therapeutic (TECX) | 2.9 | $8.0M | 512k | 15.69 | |
| Biohaven (BHVN) | 2.6 | $7.2M | 479k | 15.01 | |
| Artiva Biotherapeutics (ARTV) | 2.5 | $6.8M | 2.4M | 2.87 | |
| Surrozen Com New (SRZN) | 1.5 | $4.0M | 310k | 12.88 | |
| Protara Therapeutics Com Stk (TARA) | 1.3 | $3.5M | 800k | 4.35 | |
| Alector (ALEC) | 1.1 | $2.9M | 996k | 2.96 | |
| Silence Therapeutics Ads (SLN) | 0.9 | $2.5M | 476k | 5.19 | |
| Adverum Biotechnologies Com New (ADVM) | 0.9 | $2.5M | 542k | 4.53 | |
| Rallybio Corp (RLYB) | 0.7 | $1.8M | 3.6M | 0.50 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.3 | $740k | 490k | 1.51 | |
| Mersana Therapeutics (MRSN) | 0.1 | $405k | 52k | 7.76 |
